A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…Sequences used were obtained from GenBank at NCBI (human, <i>Homo sapiens</i>, NP_076425.1; chimp, <i>Pan troglodytes</i>, XP_001160122.1; monkey, <i>Macaca mulatta</i>, NP_001244544.1; mouse, <i>Mus musculus</i>, NP_081622.1; rat, <i>Rattus norvegicus</i>, NP_001099241.1; cow, <i>Bos taurus</i>, NP_001192540.1; dog, <i>Canis lupus familiaris</i>, XP_003639160.1; chicken, <i>Gallus gallus</i>, NP_001264526.1; frog, <i>Xenopus tropicalis</i>, NP_001004910.2; zebrafish, <i>Danio rerio</i>, NP_001007377.2) and the alignment was produced using ClustalW2 [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref041" target="_blank">41</a>]. …”

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

<i>Zscan10</i> mutant females show decreased body weight. by Petra Kraus (190913)

<i>A</i>, HDACi-mediated decrease in CHK1 precedes apoptosis. by William Brazelle (358865)

Attack rate decreases with the distance between the hotspot and point of disease introduction. by Julio Benavides (182707)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. by Katherine Schubert (5452712)

Tpm3.1 knockdown leads to a decrease in the cell’s elastic modulus. by Iman Jalilian (543338)

Stability scores with refinement, no USM decreases, no W. by Jedediah M. Singer (10331212)

Recovery of decreased Hb level after DCV/ASV treatment Mean values and SDs of the Hb levels at each time point are indicated. by Nobuyuki Matsumoto (239090)

Resveratrol decreased tumor latency in <i>Sirt1^Y/+</i> mice. by Katherine V. Clark-Knowles (368164)

RNA interference-mediated decrease in Ixofin3D results in decreased <i>B. burgdorferi</i> burden in the salivary glands and in murine skin. by Sukanya Narasimhan (73432)

Inhibition of Rac1 decreases lamellipodia formation and increases endothelial permeability. by Jerome W. Breslin (548352)

One-way migration distances calculated as mid–point to mid–point of their summer and winter geographic ranges. by Hector Galbraith (636637)

Pdl1 and Orf53 expression in strain W14 increases and decreases Tc toxin release respectively. by Guowei Yang (163967)

Decrease in number of activated macrophages in demyelinated nerves subjected to 1hr ES. by Nikki A. McLean (643606)

“…Note: ES results in a significant decrease in the ED-1 IF 10d post-LPC (5d post-ES; K) and 12d post-LPC (7d post-ES; N) relative to LPC only in a pattern suggestive of movement toward lateral edges and egress (arrow). …”

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

“…<p>(<b>A</b>) PC12 cells were transfected with pMT2 or pMT2-FLAG-MK-STYX-FLAG. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and lysed at the indicated time points. …”

Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…(L) Quantitative RT-PCR showing the expression level of several flow-responsive genes after lidocaine treatment. <i>klf2a</i> expression is significantly decreased after 6 and 10 h of treatment and is restored by incubation at 34°C; 100% of expression corresponds to a normal expression level. …”